UiR-508 sustains phosphoinositide signalling and promotes aggressive phenotype of oesophageal squamous cell carcinoma

Nature Communications

Volumn 5, Issue , 2014, Pages

  Lin, Chuyong ^a   Liu, Aibin ^b   Zhu, Jinrong ^a   Zhang, Xin ^a   Wu, Geyan ^a   Ren, Pengli ^a   Wu, Jueheng ^b   Li, Mengfeng ^b   Li, Jun ^b   Song, Libing ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL POLYPHOSPHATE 4 PHOSPHATASE TYPE I; INOSITOL POLYPHOSPHATE 5 PHOSPHATASE J; MICRORNA; MICRORNA 508; PHOSPHATASE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; INPP5J PROTEIN, HUMAN; INPP5J PROTEIN, MOUSE; MIRN508 MICRORNA, HUMAN; MIRN508 MICRORNA, MOUSE; PHOSPHATIDYLINOSITOL;

CANCER; ENZYME ACTIVITY; GENE EXPRESSION; PHENOTYPIC PLASTICITY; SIGNALING;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENICITY; CELL SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EPIGENETICS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PHOSPHOINOSITIDE METABOLISM; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SURVIVAL TIME; 3' UNTRANSLATED REGION; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; CHEMISTRY; DISEASE COURSE; DNA MICROARRAY; ESOPHAGUS; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SEQUENCE HOMOLOGY; SQUAMOUS CELL CARCINOMA;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; CELLS, CULTURED; COHORT STUDIES; DISEASE PROGRESSION; EPIGENESIS, GENETIC; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHATIDYLINOSITOLS; PHOSPHORIC MONOESTER HYDROLASES; SEQUENCE HOMOLOGY, NUCLEIC ACID; SIGNAL TRANSDUCTION;

EID: 84907326680     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms5620     Document Type: Article

References (40)

1. Boss, W. F. & Im, Y. J. Phosphoinositide signaling. Annu. Rev. Plant. Biol. 63, 409-429 (2012).
2. Wymann, M. P. & Schneiter, R. Lipid signalling in disease. Nat. Rev. Mol. Cell. Biol. 9, 162-176 (2008). (Pubitemid 351158917)
3. Engelman, J. A., Luo, J. & Cantley, L. C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7, 606-619 (2006). (Pubitemid 44100518)
4. Vanhaesebroeck, B., Stephens, L. & Hawkins, P. PI3K signalling: the path to discovery and understanding. Nat. Rev. Mol. Cell. Biol. 13, 195-203 (2012).
5. Vicinanza, M., D'Angelo, G., Di Campli, A. & De Matteis, M. A. Phosphoinositides as regulators of membrane trafficking in health and disease. Cell. Mol. Life Sci. 65, 2833-2841 (2008).
6. Alessi, D. R. et al. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol. 7, 776-789 (1997). (Pubitemid 27441832)
7. Stephens, L. et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279, 710-714 (1998). (Pubitemid 28144551)
8. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. & Hemmings, B. A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789 (1995). (Pubitemid 26004411)
9. Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K. L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell. Biol. 4, 648-657 (2002). (Pubitemid 34993700)
10. Ogg, S. et al. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389, 994-999 (1997). (Pubitemid 27485694)
11. Maehama, T. & Dixon, J. E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375-13378 (1998). (Pubitemid 28268370)
12. Ooms, L. M. et al. The inositol polyphosphate 5-phosphatase, PIPP, Is a novel regulator of phosphoinositide 3-kinase-dependent neurite elongation. Mol. Biol. Cell. 17, 607-622 (2006). (Pubitemid 43191097)
13. Ivetac, I. et al. Regulation of PI(3)K/Akt signalling and cellular transformation by inositol polyphosphate 4-phosphatase-1. EMBO Rep. 10, 487-493 (2009).
14. Ko, F. C. et al. Akt phosphorylation of deleted in liver cancer 1 abrogates its suppression of liver cancer tumorigenesis and metastasis. Gastroenterology 139, 1397-1407 (2010).
15. Vivanco, I. & Sawyers, C. L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489-501 (2002). (Pubitemid 37328931)
16. Serra, V. et al. NVP-BEZ235, a dual PI3K/mTOR inhibitor, prevents PI3K signaling and inhibits the growth of cancer cells with activating PI3K mutations. Cancer Res. 68, 8022-8030 (2008).
17. Engelman, J. A. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat. Rev. Cancer 9, 550-562 (2009).
18. Zhang, J., Roberts, T. M. & Shivdasani, R. A. Targeting PI3K signaling as a therapeutic approach for colorectal cancer. Gastroenterology 141, 50-61 (2011).
19. Yuan, T. L. & Cantley, L. C. PI3K pathway alterations in cancer: variations on a theme. Oncogene 27, 5497-5510 (2008).
20. Bachman, K. E. et al. The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol. Ther. 3, 772-775 (2004). (Pubitemid 41351083)
21. Moscatello, D. K., Holgado-Madruga, M., Emlet, D. R., Montgomery, R. B. & Wong, A. J. Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor. J. Biol. Chem. 273, 200-206 (1998). (Pubitemid 28042194)
22. Downward, J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22 (2003). (Pubitemid 37328883)
23. Ambros, V. The functions of animal microRNAs. Nature 431, 350-355 (2004). (Pubitemid 39265675)
24. Song, J. H. & Meltzer, S. J. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology 143, 35-47 e32 (2012).
25. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
26. Li, B. et al. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Int. J. Cancer 125, 2576-2585 (2009).
27. Tachibana, M. et al. Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma. Cancer 94, 1955-1960 (2002). (Pubitemid 34270048)
28. Bielas, S. L. et al. Mutations in INPP5E, encoding inositol polyphosphate-5-phosphatase E, link phosphatidyl inositol signaling to the ciliopathies. Nat. Genet. 41, 1032-1036 (2009).
29. Dyson, J. M., Fedele, C. G., Davies, E. M., Becanovic, J. & Mitchell, C. A. Phosphoinositide phosphatases: just as important as the kinases. Subcell. Biochem. 58, 215-279 (2012).
30. Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947 (1997). (Pubitemid 27148818)
31. Steck, P. A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15, 356-362 (1997). (Pubitemid 27147102)
32. Carracedo, A., Alimonti, A. & Pandolfi, P. P. PTEN level in tumor suppression: how much is too little? Cancer Res. 71, 629-633 (2011).
33. Ye, Y. et al. PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma. Nat. Commun. 4, 1508 (2013).
34. Ivetac, I. et al. The type Ialpha inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane. Mol. Biol. Cell. 16, 2218-2233 (2005). (Pubitemid 40632207)
35. Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563-572 (2002). (Pubitemid 37328923)
36. Welch, D. R. Microarrays bring new insights into understanding of breast cancer metastasis to bone. Breast Cancer Res. 6, 61-64 (2004). (Pubitemid 38324843)
37. Steeg, P. S. Metastasis suppressors alter the signal transduction of cancer cells. Nat. Rev. Cancer 3, 55-63 (2003). (Pubitemid 37328887)
38. Andl, C. D. et al. Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J. Biol. Chem. 278, 1824-1830 (2003). (Pubitemid 36801419)
39. Shimada, Y., Imamura, M., Wagata, T., Yamaguchi, N. & Tobe, T. Characterization of 21 newly established esophageal cancer cell lines. Cancer 69, 277-284 (1992).
40. Li, J. et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin. Cancer Res. 14, 3319-3326 (2008).